The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
The Centers for Disease Control and Prevention (CDC) has come out with a strong recommendation for the use of Gilead Sciences’ twice-yearly HIV pre-exposure prophylaxis (PrEP) med Yeztugo, ...
A bill moving through the Georgia General Assembly could allow trained pharmacists to prescribe PrEP, a daily medication that can prevent HIV.
Public health, explained: Sign up to receive Healthbeat’s free Atlanta newsletter here. The sharp job cuts at the Centers for Disease Control and Prevention include a successful program reducing HIV ...
If the Trump administration goes through with a plan to make major cuts to the Centers for Disease Control and Prevention’s HIV division, Georgia and other states in the Southeast would struggle to ...